ANI Pharmaceuticals, Inc.

Recently, ANI team members had the privilege of attending the EULAR - European Alliance of Associations for Rheumatology 2024 Congress in Vienna, Austria. This premier event brought together patients, healthcare professionals, and industry partners from around the world to share the latest insights and advancements that are shaping the future of #rheumatology. We enjoyed engaging with thought leaders and discussing improving the care and management of rheumatic disease. Our on-site team included Michael J. Dittbenner (Executive Director, SD&A, U.S. Rare Disease), Jason James, MBA (Director, SD&A, Rare Disease), and Grace Hsueh, PharmD from our medical affairs team. Also pictured: members of the Association of Women in Rheumatology (AWIR). Many thanks to EULAR for hosting such an inspiring and informative event. We look forward to attending AWIR’s Annual Conference this month! #ANIP #raredisease #pharmaceuticals

This July 4th, we reflect on the values of liberty and innovation that inspire the entire ANI team. Across the USA, our diverse workforce collaborates across borders to advance our mission of “Serving Patient & Improving Lives.” As we celebrate America's independence, we're thankful for the freedoms and opportunities that fuel progress worldwide. To our US team, happy Independence Day, and to all our colleagues around the globe, thank you for your dedication! #July4th #pharmaceuticals #ANIP

We honor the vibrant LGBTQ+ community both within ANI Pharmaceuticals, Inc. and across the globe. Pride Month serves as a potent reminder of the ongoing journey towards acceptance, inclusion, and equality for all. At ANI, we're committed to fostering an environment where every individual can authentically be themselves. Our strength lies in the diverse perspectives and experiences each brings to organizations. This strength fuels innovation and enhances our ability to make a meaningful impact. To all our allies: your support is invaluable in creating an inclusive workplace. Together, we're building a company culture that goes beyond acceptance to celebrate our differences, acknowledging that our diverse perspectives have the power to propel us forward on our purpose of ‘Serving Patients, Improving Lives’.

In a move to further strengthen ANI’s Rare Disease business, we announced today that we have signed a definitive agreement to acquire Alimera Sciences. This acquisition aligns with our growth strategy, further strengthening our Rare Disease business as the largest driver of future growth and expanding our presence in ophthalmology. The acquisition of Alimera adds two durable commercial assets with significant growth potential. For details, including webcast replay information from this morning’s call with ANI leadership, read our full press release on the ANI website. #ANIP #raredisease #pharmamergers #ophthalmology

This Certified Nursing Assistants Week, we join the industry in honoring the dedicated #nursingassistants who go above and beyond for patients in need. CNAs play a crucial role on healthcare teams – offering compassionate assistance with daily activities, maintaining a safe environment, and providing comfort during life’s most vulnerable moments. ANI is proud to stand with you and support the vital work that you do – this week and always. #ANIP #CNAweek

Please join us in congratulating ANI CEO Nikhil Lalwani, who is an Entrepreneur Of The Year® 2024 New Jersey Award winner! With this award, Nikhil joins an esteemed multi-industry community of entrepreneurs who have driven their companies’ success, transformed their industries, and made a positive impact on their employees and communities. Thank you EY for recognizing Nikhil for outstanding entrepreneurial leadership, driving impressive growth, and patient impact! #EOYUS #EOYNJ #ANIP #servingpatients #improvinglives

ANI’s Chief Executive Officer Nikhil Lalwani will present at the 2024 Jefferies Global Healthcare Conference in New York City at 3:30 ET on Wednesday, June 5, 2024. For webcast details, read our press release (linked in the comments section below). #ANIP #investors #pharmaceuticals

At ANI, our strong culture is the foundation for everything we do. It guides how we work together, treat each other, and pursue our business goals. That's why we're thrilled to recognize the first quarter 2024 recipients of the ANI Culture Keeper Award for their outstanding contributions in exemplifying and promoting our core values: Sandeep Komire, Senior Chemist Tammy Armstrong, Contracts & Government Pricing Specialist Dianne Balducci, Field Reimbursement Director, Rare Disease Michael J. Dittbenner, Executive Director Strategic Development & Advocacy Stacy Torgeson, Sr. Supervisor, Operations Heather Hait, Senior Manager Regulatory Affairs   These cultural ambassadors exemplify what it means to be an ANI team member. Through their dedication, they inspire us all. Please join us in congratulating these ANI team members. #ANIP #CompanyCulture #EmployeeRecognition

🚶#ICYMI - The 37 Mile Challenge in May is happening NOW! There is still time to join our virtual community of inspiring people all getting active and raising funds to help the 37 million Americans with kidney disease, like Pal, Senior Director, ANI Pharmaceuticals, Inc. East Windsor! Q: Do you have a personal connection to kidney disease? A: "My uncle in India experienced kidney failure, which caused a great deal of stress for our entire family as we worked to get him a kidney transplant. The rise in diabetes and blood pressure is unfortunately leading to a corresponding increase in kidney problems. Because of this, prevention is crucial to managing this growing challenge." Q: Why are you participating in the 37 Mile Challenge? A: “Let's raise awareness about kidney health! Maintaining a healthy lifestyle with a nutritious diet, regular exercise like yoga or daily walks, is crucial for overall well-being and can help prevent kidney problems. My wife and I enjoy daily walks and yoga, which we spread throughout the day. These habits contribute to our weight management and overall health.” Q: How do you plan on getting active during the challenge? A: “My wife and I are already committed to daily walks and yoga, incorporating them throughout our day. This 37-mile challenge is an exciting opportunity for us! We'll keep up our walks, but also use this as a springboard to spread the message of healthy living through good diet and habits.” Q: What do you wish others knew about AKF and the 37 Mile Challenge? A: “A nutritious diet, regular exercise (like yoga or daily walks), are all essential for a healthy body and mind. If you're new to exercise, consider starting with a 37-mile challenge – it's a great starting point, and you can gradually increase the distance as you get fitter. Walking offers more than just physical benefits. It can boost your mood and spark creativity. Listen to music, audiobooks, or inspiring speeches while you walk. You can even record your thoughts – who knows, they might turn into a book someday! Some of my own poem collection in Tamil actually originated from ideas that came to me while walking.” Thank you, Pal, for your support and for helping us spread awareness about the 37 million Americans with kidney disease. And, thank you, ANI Pharmaceuticals, Inc. for your support of the Spring 37 Mile Challenge! Join Pal and join the 37 Mile Challenge in May: https://bit.ly/4aBLqHh

Today is #WorldMSDay. This year’s campaign theme, “My MS Diagnosis: Navigating MS together,” highlights the barriers to diagnosing #MS and the importance of building supportive communities and systems for patients living with this complex disease. ANI supports and applauds the National MS Society's work to promote awareness and help improve the lives of those impacted by MS. #ANIP #MSAwareness